ArticleBMC cancer2018

BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia.

Yafeng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.